LOX and adenocarcinoma: Differential effects of the ECM on lung cancer histology have also been noted in the context of LKB1-negative tumors, where LOX-dependent collagen crosslinking can drive the transdifferentiation of adenocarcinomas to SqCC [140], although the precise mechanism by which the ECM potentially modulates lung cancer histology remains unclear.